Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
8.75
+0.63 (7.76%)
At close: Apr 28, 2026, 4:00 PM EDT
8.79
+0.04 (0.46%)
After-hours: Apr 28, 2026, 7:59 PM EDT
Sagimet Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | - | - | 2 | - | - | |
| Gross Profit | - | - | 2 | - | - | |
| Selling, General & Admin | 17.84 | 16.01 | 12.96 | 6.14 | 4.38 | |
| Research & Development | 39.05 | 38.44 | 19.78 | 24.92 | 19.34 | |
| Operating Expenses | 56.89 | 54.45 | 32.74 | 31.06 | 23.72 | |
| Operating Income | -56.89 | -54.45 | -30.74 | -31.06 | -23.72 | |
| Interest & Investment Income | 5.85 | 8.89 | 2.86 | 0.55 | 0.03 | |
| Other Non Operating Income (Expenses) | - | - | 0 | 0 | -0.75 | |
| EBT Excluding Unusual Items | -51.04 | -45.57 | -27.88 | -30.5 | -24.44 | |
| Pretax Income | -51.04 | -45.57 | -27.88 | -30.5 | -24.44 | |
| Net Income | -51.04 | -45.57 | -27.88 | -30.5 | -24.44 | |
| Net Income to Common | -51.04 | -45.57 | -27.88 | -30.5 | -24.44 | |
| Shares Outstanding (Basic) | 32 | 31 | 10 | 0 | 0 | |
| Shares Outstanding (Diluted) | 32 | 31 | 10 | 0 | 0 | |
| Shares Change (YoY) | 3.17% | 199.71% | 5565.90% | 50.61% | 26.95% | |
| EPS (Basic) | -1.58 | -1.45 | -2.66 | -165.20 | -199.40 | |
| EPS (Diluted) | -1.58 | -1.45 | -2.66 | -165.20 | -199.40 | |
| Gross Margin | - | - | 100.00% | - | - | |
| Operating Margin | - | - | -1537.00% | - | - | |
| Profit Margin | - | - | -1393.80% | - | - | |
| EBIT | -56.89 | -54.45 | -30.74 | -31.06 | -23.72 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.